<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Nephrol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Nephrol</journal-id>
      <journal-title-group>
        <journal-title>BMC Nephrology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2369</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23663351</article-id>
      <article-id pub-id-type="pmc">3662586</article-id>
      <article-id pub-id-type="publisher-id">1471-2369-14-104</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2369-14-104</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A novel <italic>TRPC6</italic> mutation in a family with podocytopathy and clinical variability</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Mottl</surname>
            <given-names>Amy K</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>amy_mottl@med.unc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Lu</surname>
            <given-names>Mei</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mlu@unch.unc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Fine</surname>
            <given-names>Catherine A</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>catherine_fine@med.unc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Weck</surname>
            <given-names>Karen E</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>karen_weck@med.unc.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>University of North Carolina Kidney Center, UNC School of Medicine, Chapel Hill, NC, USA</aff>
      <aff id="I2"><label>2</label>Department of Pathology &amp; Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA</aff>
      <aff id="I3"><label>3</label>Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC, USA</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <volume>14</volume>
      <fpage>104</fpage>
      <lpage>104</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Mottl et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Mottl et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2369/14/104"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Mutation in several podocyte-specific genes have been noted to result in phenotypic heterogeneity. Herein, we report a novel, autosomal dominant <italic>TRPC6</italic> mutation in a family with disease ranging from asymptomatic minimal change disease to end-stage kidney disease.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 35 year old woman developed asymptomatic, nephrotic range proteinuria during pregnancy that did not resolve after delivery. Her mother had end-stage kidney disease of unknown etiology and her brother had asymptomatic proteinuria. Kidney biopsy revealed minimal change disease in both the proband and her brother. Genetic testing was performed in the proband and mother, revealing a novel frameshift mutation in <italic>TRPC6</italic>, D873fsX878. The proband continues to have subnephrotic range proteinuria and normal creatinine but her brother has since developed progressive chronic kidney disease.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The current case report underscores the heterogeneity of disease in podocytopathies and related genes. Genetic testing of podocyte genes is useful in order to understand the pathophysiologic processes underlying these overlapping diseases.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Proteinuria</kwd>
        <kwd>Minimal change disease</kwd>
        <kwd>Focal segmental glomerulosclerosis</kwd>
        <kwd>Genetic testing</kwd>
        <kwd>TRPC6</kwd>
        <kwd>Genotype-phenotype correlation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Diseases of the podocyte most commonly manifest as minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) in children and adults, respectively. A substantial proportion of both diseases are due to genetic aberrations of genes that are important to podocyte structure or function. The majority of the currently recognized genetic forms of MCD and FSGS follow simple Mendelian inheritance patterns [<xref ref-type="bibr" rid="B1">1</xref>]. Mutation in the podocyte-specific gene <italic>TRPC6</italic> was first identified as causing autosomal dominant (AD) FSGS in 2005 [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. A total of 16 mutations in <italic>TRPC6</italic> have since been cited in both familial and sporadic FSGS as well as in adult and childhood onset disease [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. To date, only a single family has been identified as having kidney histopathology other than FSGS [<xref ref-type="bibr" rid="B8">8</xref>]. Herein, we add to this body of literature by reporting a novel <italic>TRPC6</italic> mutation in a family with phenotypic heterogeneity ranging from asymptomatic minimal change disease to end-stage kidney disease (ESKD).</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 34 year-old Korean woman was in her first trimester of pregnancy when she developed proteinuria. She was not edematous and did not have hypertension. Her proteinuria became increasingly severe and by her third trimester of pregnancy her urine protein to creatinine ratio (UPC) was greater than 10 gm/gm. She was induced at 37 weeks gestation and delivered a healthy boy who had no complications. Her proteinuria did not resolve following delivery and percutaneous kidney biopsy was performed. This demonstrated 1 out of 20 globally sclerotic glomeruli with no other abnormalities on light microscopy. Immunofluorescent staining was negative. Electron microscopy revealed moderate podocyte effacement and segmental basement membrane thinning. She has persistently declined treatment, including use of angiotensin converting enzyme inhibitors and all forms of immunomodulatory therapy. Despite this, her UPC has been stable for several years at 1.0 gm/gm and her creatinine has consistently measured less than 1.0 gm/dl.</p>
      <p>There was suspicion of a genetic component to her disease as her mother had developed end-stage kidney disease in her mid-50s and her brother had proteinuria progressing to chronic kidney disease (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). The mother presented with shrunken kidneys and had not been able to undergo biopsy; she underwent kidney transplantation at 55 years and has had no proteinuria since that time. The brother&#x2019;s clinical history has not been confirmed due to lack of consent. Per his sister&#x2019;s report, proteinuria was initially mild and he opted against kidney biopsy until his proteinuria worsened and he subsequently developed chronic renal insufficiency. His biopsy reportedly demonstrated minimal change disease and he was treated with oral steroids without any improvement.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>
            <bold>Genealogical tree of a non-consanguineous, Korean family with minimal change disease and a novel </bold>
            <bold>
              <italic>TRPC6 </italic>
            </bold>
            <bold>deletion mutation in exon 12.</bold>
          </p>
        </caption>
        <graphic xlink:href="1471-2369-14-104-1"/>
      </fig>
      <p>Genetic testing of <italic>TRPC6</italic> was performed due to the apparent autosomal dominant inheritance pattern. She was found to be heterozygous for a novel <italic>TRPC6</italic> frameshift mutation resulting from a 4 base pair GATA deletion in exon 12 [c. 2617&#x2013;2620 del GATA, p. D873fsX878] (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>). The reported mutation is novel, as it has not been seen in over 90 patients with nephrotic syndrome sequenced in our laboratory, is not reported in any dbSNP or exome sequencing databases of normal controls, and has not been previously reported in <italic>TRPC6</italic>. The resultant frameshift leads to a premature stop codon, and is predicted to result in a truncated TRPC6 protein lacking the C-terminal coiled coil domain. The proband&#x2019;s mother also tested positive for the same mutation but her brother did not wish to be tested. DNA sequencing for mutations in <italic>ACTN4, INF2,</italic> and <italic>NPHS2</italic> associated with adolescent or adult onset nephrotic syndrome revealed no other mutations in this family (data not shown). Due to segmental basement membrane thinning on the proband&#x2019;s kidney biopsy and the possibility of X-linked transmission in this family, the collagen 4 alpha 5 (<italic>COL4A5</italic>) gene was also sequenced in the proband&#x2019;s mother and was negative for mutations.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Sequence analysis of the novel </bold><bold><italic>TRPC6 </italic></bold><bold>mutation found in 3 family members.</bold> Shown is a partial electropherogram of Sanger DNA sequencing analysis of <italic>TRPC6</italic> exon12 from the proband. The arrow shows the position of the heterozygous four base pair deletion resulting in a downstream frameshift. Shown above are the nucleotide and predicted amino acid sequences of the wild-type <italic>TRPC6</italic> sequence (top line) and the heterozygous four base pair deletion (bottom line). The deleted nucleotides (GATA) are depicted in red font. The four base pair deletion results in a frame shift and premature protein truncation, five amino acids downstream [p.D873fsX878].</p>
        </caption>
        <graphic xlink:href="1471-2369-14-104-2"/>
      </fig>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>TRPC6 is a transient receptor potential (TRP) channel that plays a role in intracellular calcium signaling and is expressed in a signaling complex with nephrin and podocin in the podocyte slit diaphragm [<xref ref-type="bibr" rid="B1">1</xref>]. Although the reported <italic>TRPC6</italic> frameshift mutation is novel, it encodes a truncated TRPC6 protein lacking the C-terminal coiled coil domain, a highly conserved domain thought to play an essential role in TRPC6 calcium channel function. This truncating mutation is likely to have a dominant gain-of-function effect similar to other known pathogenic <italic>TRPC6</italic> mutations (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Other <italic>TRPC6</italic> mutations mapped to the coiled-coil domain at the C-terminus, such as R895C and E897K, have been demonstrated to result in increased calcium ion influx [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. The C-terminal K874X nonsense mutation and N-terminal mutations within the ankyrin repeats have demonstrated delayed calcium channel inactivation, resulting in increased channel opening time [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. The D873fsX878 mutation results in protein truncation only four amino acids downstream of the truncating K874X mutation and may have a similar effect on delaying calcium channel inactivation. The tracking of this mutation with nephrotic syndrome in this family supports an autosomal dominant gain of function effect. The mechanism whereby increased calcium current leads to the pathogenic manifestations of MCD or FSGS is unknown. TRPC6 functions as a mechanoreceptor of membrane stretch [<xref ref-type="bibr" rid="B1">1</xref>]. Other pathogenic mechanisms of <italic>TRPC6</italic> mutation that have been hypothesized include altered channel regulation, altered interaction with other slit diaphragm proteins, and altered protein turnover [<xref ref-type="bibr" rid="B3">3</xref>]. It has been speculated that mutations in <italic>TRPC6</italic> may result in apoptosis, podocyte detachment or an alteration in the ultrafiltration coefficient [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Mutations in TRPC6 protein currently identified to cause proteinuric kidney disease</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="center">
                <bold>TRPC6 mutation</bold>
              </th>
              <th align="center">
                <bold>Effect on ion channel function</bold>
              </th>
              <th align="center">
                <bold>Level of evidence</bold>
              </th>
              <th align="center">
                <bold>Ethnicity</bold>
              </th>
              <th align="center">
                <bold>Phenotype</bold>
              </th>
              <th align="center">
                <bold>Age at presentation (years)</bold>
              </th>
              <th align="center">
                <bold>Reference</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="center" valign="bottom">89fsX8<hr/></td>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">FSGS<hr/></td>
              <td align="center" valign="bottom">7<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B7">7</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">G109S<hr/></td>
              <td align="center" valign="bottom">Probably damaging<hr/></td>
              <td align="center" valign="bottom">In silico scoring matrix<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">FSGS<hr/></td>
              <td align="center" valign="bottom">25<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B6">6</xref>]<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="center" valign="top">N125S<hr/></td>
              <td align="center" valign="bottom">Probably damaging<hr/></td>
              <td align="center" valign="bottom">In silico scoring matrix<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">sporadic FSGS<hr/></td>
              <td align="center" valign="bottom">41<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B6">6</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">Increased intracellular calcium<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">MCD and IgAN with MPGN-like pattern<hr/></td>
              <td align="center" valign="bottom">4-14<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B8">8</xref>]<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="center" valign="top">M132T<hr/></td>
              <td align="center" valign="bottom">Increased current amplitude and delayed channel inactivation<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">9-30<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B5">5</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">FSGS<hr/></td>
              <td align="center" valign="bottom">8<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B7">7</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">P112Q<hr/></td>
              <td align="center" valign="bottom">Increased current amplitude<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">30-40<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B2">2</xref>]<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="center" valign="top">N143S<hr/></td>
              <td align="center" valign="bottom">None identified<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">African American<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">30-40<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B3">3</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">None identified<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">27-39<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B5">5</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">H218L<hr/></td>
              <td align="center" valign="bottom">Increased intracellular calcium<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">sporadic FSGS<hr/></td>
              <td align="center" valign="bottom">8<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B8">8</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">S270T<hr/></td>
              <td align="center" valign="bottom">None identified<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Latino<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">20-50<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B3">3</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">R360H<hr/></td>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Not stated<hr/></td>
              <td align="center" valign="bottom">FSGS<hr/></td>
              <td align="center" valign="bottom">34<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B11">11</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">L395A<hr/></td>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">sporadic FSGS<hr/></td>
              <td align="center" valign="bottom">2<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">G757D<hr/></td>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">FSGS<hr/></td>
              <td align="center" valign="bottom">1<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B7">7</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">L780P<hr/></td>
              <td align="center" valign="bottom">Possibly damaging<hr/></td>
              <td align="center" valign="bottom">In silico scoring matrix<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">sporadic FSGS<hr/></td>
              <td align="center" valign="bottom">7<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B6">6</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">D873fsX878<hr/></td>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">MCD<hr/></td>
              <td align="center" valign="bottom">34-50<hr/></td>
              <td align="center" valign="bottom">Present study<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">K874X<hr/></td>
              <td align="center" valign="bottom">None identified<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">30-60<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B3">3</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">Q889K<hr/></td>
              <td align="center" valign="bottom">Increased current amplitude<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Chinese<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">&gt;12<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B4">4</xref>]<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="center" valign="top">R895C<hr/></td>
              <td align="center" valign="bottom">Increased current amplitude<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Latino<hr/></td>
              <td align="center" valign="bottom">AD FSGS<hr/></td>
              <td align="center" valign="bottom">20-50<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B3">3</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">Not evaluated<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">AD collapsing FSGS<hr/></td>
              <td align="center" valign="bottom">21-38<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B9">9</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">R895L<hr/></td>
              <td align="center" valign="bottom">Increased intracellular calcium<hr/></td>
              <td align="center" valign="bottom">In Vitro experiments<hr/></td>
              <td align="center" valign="bottom">Caucasian<hr/></td>
              <td align="center" valign="bottom">sporadic collapsing FSGS<hr/></td>
              <td align="center" valign="bottom">1<hr/></td>
              <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B8">8</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="center">E897K</td>
              <td align="center">Increased current amplitude</td>
              <td align="center">In Vitro experiments</td>
              <td align="center">Caucasian</td>
              <td align="center">AD FSGS</td>
              <td align="center">25-35</td>
              <td align="center">[<xref ref-type="bibr" rid="B3">3</xref>]</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>AD-Autosomal Dominant; FSGS-Focal Segmental Glomerulosclerosis; MCD-Minimal Change Disease; IgAN-IgA Nephropathy; MPGN-Membranoproliferative Glomerulosclerosis.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>To date, the vast majority of identified mutations in <italic>TRPC6</italic> have been associated with FSGS, including collapsing glomerulopathy [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. The current report underscores the phenotypic heterogeneity that can occur in podocyte-specific gene mutations. We have replicated the finding that <italic>TRPC6</italic> mutation can result in MCD as well as FSGS [<xref ref-type="bibr" rid="B8">8</xref>]. Gigante et al. (2011) previously reported a family with a distinct <italic>TRPC6</italic> mutation resulting in childhood onset nephrotic syndrome, with one sibling having MCD and another having IgAN with a membranoproliferative-like pattern. In some cases, the finding of MCD is due to unsampled FSGS and in other instances it may represent an earlier clinical stage of FSGS, which could be true in the present case. <italic>TRPC6</italic> mutation has traditionally been thought to cause familial, adult onset disease; however, a significant number of sporadic and childhood onset FSGS cases have been identified [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Other podocyte-specific genes have also been found to result in multiple pathologic and clinical disease phenotypes. Mutations in podocin (<italic>NPHS2</italic>) have been reported in FSGS, steroid resistant MCD and diffuse mesangial sclerosis [<xref ref-type="bibr" rid="B14">14</xref>]. Phenotypic heterogeneity also exists for nephrin (<italic>NPHS1</italic>) mutations which have been reported to result in congenital nephrotic syndrome, steroid-resistant MCD and FSGS [<xref ref-type="bibr" rid="B15">15</xref>]. Given the heterogeneity in disease that can result from mutations within the same gene, it has been suggested that these disease entities be referred to as &#x2018;podocytopathies&#x2019; rather than by their histologic phenotype [<xref ref-type="bibr" rid="B16">16</xref>].</p>
      <p>This family demonstrates the significant heterogeneity in clinical manifestations that can occur from the same genetic mutation. Although genotype-phenotype correlation of this novel <italic>TRPC6</italic> mutation is not known, all three affected adults presented with proteinuria at 32&#x2013;34 years of age, with progressive chronic kidney disease subsequently developing in the proband&#x2019;s mother and brother. However, the proband has thus far remained stable following pregnancy-induced proteinuria without any increase in creatinine. There are likely other genetic and/or environmental modifiers that play a significant role in disease penetrance and expressivity. Currently, there are no known genetic modifiers of <italic>TRPC6</italic>-associated disease. Modifiers for <italic>TRPC6</italic>-mediated podocytopathies can be speculated when considering that TRPC6 is partially regulated by podocin and is thought to be assembled in a complex with nephrin. The R229Q single nucleotide polymorphism in podocin (<italic>NPHS2)</italic> results in decreased nephrin binding and can result in both familial and seemingly sporadic FSGS when in a compound heterozygous state with another deleterious <italic>NPHS2</italic> mutation [<xref ref-type="bibr" rid="B17">17</xref>]. Heterozygous lesions in collagen IV have also been hypothesized to modify susceptibility to FSGS [<xref ref-type="bibr" rid="B18">18</xref>]. Although sequence analysis of both <italic>NPHS2</italic> and the X-linked collagen IV chain gene <italic>COL4A5</italic> was negative in this family, other genetic or environmental factors may play a role in modifying disease severity within a family and in determining whether <italic>TRPC6</italic> mutation presents as FSGS or MCD in different families.</p>
      <p>This case report underscores the complexity in nomenclature, pathogenesis and genetics of podocytopathies. The clinical presentation, histological pattern, causative genes and specific mutations should all be taken into consideration when assessing a familial or even seemingly sporadic case of proteinuria. Documentation of atypical cases of familial proteinuric syndromes along with technological advances in genetic testing will facilitate a better understanding of diseases of the podocyte.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written, informed consent was obtained from the patient for publication of this case report.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>MCD: Minimal Change Disease; FSGS: Focal Segmental Glomerulosclerosis; ESKD: End-Stage Kidney Disease.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>AKM and CAF provided care to the proband. ML and KEW were responsible for genetic testing. AKM wrote the manuscript. All authors held discussions regarding the content of the manuscript and approved the final version of the manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2369/14/104/prepub">http://www.biomedcentral.com/1471-2369/14/104/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>Only the authors contributed to this manuscript. Dr. Mottl is partially funded by the NIDDK 1K23DK093804-01 and CDC/NIDDK 1U18DP002708-01. Dr. Weck is partially funded by Susan Komen grant #KG100355, NIH/NCATS 5-UL1RR025747-04 and NIH/NHGR 5-U01HG006487-02. Dr. Lu is partially funded by NIH/NCATS 5-UL1RR025747-04.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Machuca</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Benoit</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Antignac</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology</article-title>
          <source>Hum Mol Genet</source>
          <year>2009</year>
          <volume>18</volume>
          <issue>R2</issue>
          <fpage>R185</fpage>
          <lpage>R194</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddp328</pub-id>
          <pub-id pub-id-type="pmid">19808795</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Winn</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Conlon</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Lynn</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Farrington</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Creazzo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hawkins</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Daskalakis</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kwan</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Ebersviller</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Burchette</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Pericak-Vance</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Vance</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>PB</given-names>
          </name>
          <article-title>A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <issue>5729</issue>
          <fpage>1801</fpage>
          <lpage>1804</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1106215</pub-id>
          <pub-id pub-id-type="pmid">15879175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Reiser</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Polu</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Moller</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Kenlan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Altintas</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Faul</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Herbert</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Villegas</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Avila-Casado</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>McGee</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sugimoto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kalluri</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mundel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Clapham</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Pollak</surname>
            <given-names>MR</given-names>
          </name>
          <article-title>TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function</article-title>
          <source>Nat Genet</source>
          <year>2005</year>
          <volume>37</volume>
          <issue>7</issue>
          <fpage>739</fpage>
          <lpage>744</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1592</pub-id>
          <pub-id pub-id-type="pmid">15924139</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>ZH</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>XX</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>WM</given-names>
          </name>
          <article-title>Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients</article-title>
          <source>Mutat Res</source>
          <year>2009</year>
          <volume>664</volume>
          <issue>1&#x2013;2</issue>
          <fpage>84</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">19124028</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Heeringa</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Moller</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yue</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hinkes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chernin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Vlangos</surname>
            <given-names>CN</given-names>
          </name>
          <name>
            <surname>Hoyer</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Reiser</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hildebrandt</surname>
            <given-names>F</given-names>
          </name>
          <article-title>A novel TRPC6 mutation that causes childhood FSGS</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <issue>11</issue>
          <fpage>e7771</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0007771</pub-id>
          <pub-id pub-id-type="pmid">19936226</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ars</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rossetti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Salido</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Garcia-Maset</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gimenez</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mendizabal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Luciano Nieto</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pena</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Camacho</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Fraga</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cobo</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bernis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ortiz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>de Pablos</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Sanchez-Moreno</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pintos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mirapeix</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fernandez-Llama</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ballarin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Torra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zamora</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lopez-Hellin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Madrid</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ventura</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vilalta</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Espinosa</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>C</given-names>
          </name>
          <article-title>TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2009</year>
          <volume>24</volume>
          <issue>10</issue>
          <fpage>3089</fpage>
          <lpage>3096</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfp229</pub-id>
          <pub-id pub-id-type="pmid">19458060</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buscher</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Kranz</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Buscher</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hildebrandt</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dworniczak</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pennekamp</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kuwertz-Broking</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wingen</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>John</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Kemper</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Monnens</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hoyer</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Konrad</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome</article-title>
          <source>Clin J Am Soc Nephrol</source>
          <year>2010</year>
          <volume>5</volume>
          <issue>11</issue>
          <fpage>2075</fpage>
          <lpage>2084</lpage>
          <pub-id pub-id-type="doi">10.2215/CJN.01190210</pub-id>
          <pub-id pub-id-type="pmid">20798252</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gigante</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Caridi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Montemurno</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Soccio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D&#x2019;Apolito</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cerullo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Aucella</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Schirinzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Emma</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Massella</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Messina</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>De Palo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ranieri</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ghiggeri</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Gesualdo</surname>
            <given-names>L</given-names>
          </name>
          <article-title>TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype</article-title>
          <source>Clin J Am Soc Nephrol</source>
          <year>2011</year>
          <volume>6(</volume>
          <issue>7</issue>
          <fpage>1626</fpage>
          <lpage>1634</lpage>
          <pub-id pub-id-type="pmid">21734084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liakopoulos</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Huerta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pollak</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Sirota</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Superdock</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Appel</surname>
            <given-names>GB</given-names>
          </name>
          <article-title>Familial collapsing focal segmental glomerulosclerosis</article-title>
          <source>Clin Nephrol</source>
          <year>2011</year>
          <volume>75</volume>
          <issue>4</issue>
          <fpage>362</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">21426891</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mir</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yavascan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Berdeli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sozeri</surname>
            <given-names>B</given-names>
          </name>
          <article-title>TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2012</year>
          <volume>27</volume>
          <issue>1</issue>
          <fpage>205</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfr202</pub-id>
          <pub-id pub-id-type="pmid">21511817</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buscher</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Konrad</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nagel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Witzke</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Kribben</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hoyer</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients</article-title>
          <source>Clin Nephrol</source>
          <year>2012</year>
          <volume>78</volume>
          <issue>1</issue>
          <fpage>47</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">22732337</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>El Hindi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reiser</surname>
            <given-names>J</given-names>
          </name>
          <article-title>TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease</article-title>
          <source>Pediatr Nephrol</source>
          <year>2011</year>
          <volume>26</volume>
          <issue>7</issue>
          <fpage>1057</fpage>
          <lpage>1064</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-010-1718-4</pub-id>
          <pub-id pub-id-type="pmid">21161284</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Winn</surname>
            <given-names>MP</given-names>
          </name>
          <article-title>2007 Young Investigator Award: TRP'ing into a new era for glomerular disease</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2008</year>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>1071</fpage>
          <lpage>1075</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2007121292</pub-id>
          <pub-id pub-id-type="pmid">18434567</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Caridi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bertelli</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Di Duca</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dagnino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Emma</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Onetti Muda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scolari</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Miglietti</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mazzucco</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Murer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Carrea</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Massella</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rizzoni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Perfumo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ghiggeri</surname>
            <given-names>GM</given-names>
          </name>
          <article-title>Broadening the spectrum of diseases related to podocin mutations</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2003</year>
          <volume>14</volume>
          <issue>5</issue>
          <fpage>1278</fpage>
          <lpage>1286</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000060578.79050.E0</pub-id>
          <pub-id pub-id-type="pmid">12707396</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Garcia-Maset</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gimenez</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Zamora</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pena</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Madrid</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Camacho</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Fraga</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sanchez-Moreno</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cobo</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bernis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ortiz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>de Pablos</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Pintos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Justa</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Hidalgo-Barquero</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fernandez-Llama</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ballarin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ars</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Torra</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis</article-title>
          <source>Kidney Int</source>
          <year>2009</year>
          <volume>76</volume>
          <issue>12</issue>
          <fpage>1268</fpage>
          <lpage>1276</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2009.381</pub-id>
          <pub-id pub-id-type="pmid">19812541</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pollak</surname>
            <given-names>MR</given-names>
          </name>
          <article-title>Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2002</year>
          <volume>13</volume>
          <issue>12</issue>
          <fpage>3016</fpage>
          <lpage>3023</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000039569.34360.5E</pub-id>
          <pub-id pub-id-type="pmid">12444222</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Machuca</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hummel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nevo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dantal</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Al-Sabban</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Baudouin</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Abel</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Grunfeld</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Antignac</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant</article-title>
          <source>Kidney Int</source>
          <year>2009</year>
          <volume>75</volume>
          <issue>7</issue>
          <fpage>727</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2008.650</pub-id>
          <pub-id pub-id-type="pmid">19145239</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Voskarides</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pierides</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Deltas</surname>
            <given-names>C</given-names>
          </name>
          <article-title>COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?</article-title>
          <source>Connect Tissue Res</source>
          <year>2008</year>
          <volume>49</volume>
          <issue>3</issue>
          <fpage>283</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="pmid">18661361</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
